58 related articles for article (PubMed ID: 16299255)
1. In vitro and in vivo effects and mechanisms of celecoxib-induced growth inhibition of human hepatocellular carcinoma cells.
Cui W; Yu CH; Hu KQ
Clin Cancer Res; 2005 Nov; 11(22):8213-21. PubMed ID: 16299255
[TBL] [Abstract][Full Text] [Related]
2. Cox-2 inhibition enhances the activity of sunitinib in human renal cell carcinoma xenografts.
Wang X; Zhang L; O'Neill A; Bahamon B; Alsop DC; Mier JW; Goldberg SN; Signoretti S; Atkins MB; Wood CG; Bhatt RS
Br J Cancer; 2013 Feb; 108(2):319-26. PubMed ID: 23322198
[TBL] [Abstract][Full Text] [Related]
3. NS398 inhibits the growth of Hep3B human hepatocellular carcinoma cells via caspase-independent apoptosis.
Park MK; Hwang SY; Kim JO; Kwack MH; Kim JC; Kim MK; Sung YK
Mol Cells; 2004 Feb; 17(1):45-50. PubMed ID: 15055526
[TBL] [Abstract][Full Text] [Related]
4. Celecoxib enhances the therapeutic efficacy of epirubicin for Novikoff hepatoma in rats.
Chu TH; Chan HH; Hu TH; Wang EM; Ma YL; Huang SC; Wu JC; Chang YC; Weng WT; Wen ZH; Wu DC; Chen YA; Tai MH
Cancer Med; 2018 Jun; 7(6):2567-2580. PubMed ID: 29683262
[TBL] [Abstract][Full Text] [Related]
5. Epithelial-mesenchymal transition increases tumor sensitivity to COX-2 inhibition by apricoxib.
Kirane A; Toombs JE; Larsen JE; Ostapoff KT; Meshaw KR; Zaknoen S; Brekken RA; Burrows FJ
Carcinogenesis; 2012 Sep; 33(9):1639-46. PubMed ID: 22678114
[TBL] [Abstract][Full Text] [Related]
6. Eicosanoids and other oxylipins in liver injury, inflammation and liver cancer development.
Alba MM; Ebright B; Hua B; Slarve I; Zhou Y; Jia Y; Louie SG; Stiles BL
Front Physiol; 2023; 14():1098467. PubMed ID: 36818443
[TBL] [Abstract][Full Text] [Related]
7. Design, Synthesis, and Anticancer Screening for Repurposed Pyrazolo[3,4-d]pyrimidine Derivatives on Four Mammalian Cancer Cell Lines.
Othman EM; Bekhit AA; Anany MA; Dandekar T; Ragab HM; Wahid A
Molecules; 2021 May; 26(10):. PubMed ID: 34065773
[TBL] [Abstract][Full Text] [Related]
8. The Carcinogenic Agent Diethylnitrosamine Induces Early Oxidative Stress, Inflammation and Proliferation in Rat Liver, Stomach and Colon: Protective Effect of Ginger Extract.
Mansour DF; Abdallah HMI; Ibrahim BMM; Hegazy RR; Esmail RSE; Abdel-Salam LO
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2551-2561. PubMed ID: 31450931
[TBL] [Abstract][Full Text] [Related]
9. Synergistic antiproliferative effects of curcumin and celecoxib in hepatocellular carcinoma HepG2 cells.
Abdallah FM; Helmy MW; Katary MA; Ghoneim AI
Naunyn Schmiedebergs Arch Pharmacol; 2018 Dec; 391(12):1399-1410. PubMed ID: 30155693
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Cytotoxicity Effects of Chalcone Epoxide Analogues as a Selective COX-II Inhibitor in the Human Liver Carcinoma Cell Line.
Makhdoumi P; Zarghi A; Daraei B; Karimi G
J Pharmacopuncture; 2017 Sep; 20(3):207-212. PubMed ID: 30087797
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Silibinin Effects on the Viability of HepG2 (Human hepatocellular liver carcinoma) and HUVEC (Human Umbilical Vein Endothelial) Cell Lines.
Vakili Zahir N; Nakhjavani M; Hajian P; Shirazi FH; Mirzaei H
Iran J Pharm Res; 2018; 17(1):261-267. PubMed ID: 29755557
[TBL] [Abstract][Full Text] [Related]
12. Aspirin Use and Risk of Hepatocellular Carcinoma in a National Cohort Study of Korean Adults.
Hwang IC; Chang J; Kim K; Park SM
Sci Rep; 2018 Mar; 8(1):4968. PubMed ID: 29563592
[TBL] [Abstract][Full Text] [Related]
13. Persistence of Circulating Hepatitis C Virus Antigens-Specific Immune Complexes in Patients with Resolved HCV Infection.
Hu KQ; Cui W
Dig Dis Sci; 2018 May; 63(5):1237-1242. PubMed ID: 29516328
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory Effect of Aspirin on Cholangiocarcinoma Cells.
Boueroy P; Aukkanimart R; Boonmars T; Sriraj P; Ratanasuwan P; Juasook A; Wonkchalee N; Vaeteewoottacharn K; Wongkham S
Asian Pac J Cancer Prev; 2017 Nov; 18(11):3091-3096. PubMed ID: 29172284
[TBL] [Abstract][Full Text] [Related]
15. COX-2 Promotes Migration and Invasion by the Side Population of Cancer Stem Cell-Like Hepatocellular Carcinoma Cells.
Guo Z; Jiang JH; Zhang J; Yang HJ; Yang FQ; Qi YP; Zhong YP; Su J; Yang RR; Li LQ; Xiang BD
Medicine (Baltimore); 2015 Nov; 94(44):e1806. PubMed ID: 26554780
[TBL] [Abstract][Full Text] [Related]
16. GRP78/Dna K Is a Target for Nexavar/Stivarga/Votrient in the Treatment of Human Malignancies, Viral Infections and Bacterial Diseases.
Roberts JL; Tavallai M; Nourbakhsh A; Fidanza A; Cruz-Luna T; Smith E; Siembida P; Plamondon P; Cycon KA; Doern CD; Booth L; Dent P
J Cell Physiol; 2015 Oct; 230(10):2552-78. PubMed ID: 25858032
[TBL] [Abstract][Full Text] [Related]
17. OSU-03012 and Viagra Treatment Inhibits the Activity of Multiple Chaperone Proteins and Disrupts the Blood-Brain Barrier: Implications for Anti-Cancer Therapies.
Booth L; Roberts JL; Tavallai M; Nourbakhsh A; Chuckalovcak J; Carter J; Poklepovic A; Dent P
J Cell Physiol; 2015 Aug; 230(8):1982-98. PubMed ID: 25736380
[TBL] [Abstract][Full Text] [Related]
18. The association between three cyclooxygenase-2 polymorphisms and hepatocellular carcinoma risk: a meta-analysis.
Chen Z; Zhu J; Huang C; Lian F; Wu G; Zhao Y
PLoS One; 2015; 10(3):e0118251. PubMed ID: 25730260
[TBL] [Abstract][Full Text] [Related]
19. GRP78/BiP/HSPA5/Dna K is a universal therapeutic target for human disease.
Booth L; Roberts JL; Cash DR; Tavallai S; Jean S; Fidanza A; Cruz-Luna T; Siembiba P; Cycon KA; Cornelissen CN; Dent P
J Cell Physiol; 2015 Jul; 230(7):1661-76. PubMed ID: 25546329
[TBL] [Abstract][Full Text] [Related]
20. Regulation of OSU-03012 toxicity by ER stress proteins and ER stress-inducing drugs.
Booth L; Roberts JL; Cruickshanks N; Grant S; Poklepovic A; Dent P
Mol Cancer Ther; 2014 Oct; 13(10):2384-98. PubMed ID: 25103559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
